Diabetes, pro-BNP a bad mix for cardiac healthSeptember 25, 2013Lipid DisordersDiabetesCAD & Atherosclerosis
TAVR shows large survival benefit in diabetes patientsSeptember 24, 2013Interventional Cardiology & SurgeryDiabetes
Insulin-triggered hypoglycemia poses less dangerSeptember 23, 2013DiabetesCAD & AtherosclerosisLipid Disorders
Just over a third of hypertensive kidney patients are at target BPSeptember 20, 2013Lipid DisordersHypertensionDiabetes
Diabetics' stroke risk post MI has plummetedSeptember 20, 2013Acute Coronary SyndromesLipid DisordersStrokeDiabetes
Aliskiren fails to fight coronary atherosclerosisSeptember 3, 2013CAD & AtherosclerosisLipid DisordersDiabetes
Saxagliptin, alogliptin show cardiovascular safety in randomized trialsSeptember 2, 2013CAD & AtherosclerosisDiabetes
Adult diabetes rate highest in West VirginiaAugust 27, 2013Lipid DisordersDiabetesBusiness of Medicine
Controversial diabetes drug not associated with increased CV risk in patients with CADJuly 30, 2013CAD & AtherosclerosisLipid DisordersDiabetes
Osteoprotegerin ups risk of vascular events in type 1 diabetesJuly 22, 2013CAD & AtherosclerosisLipid DisordersDiabetes
Roche halts studies of experimental type 2 diabetes drug July 10, 2013CAD & AtherosclerosisLipid DisordersDiabetes
Twice daily regimen eases aspirin resistance in diabetesJuly 2, 2013CAD & AtherosclerosisLipid DisordersDiabetesInterventional Cardiology & Surgery
Empagliflozin improves cardiovascular risk factors in T2DMJuly 2, 2013CAD & AtherosclerosisLipid DisordersDiabetesPediatrics
